Skip to main content

An official website of the United States government

You have 2 new alerts

Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

info alert

Note: There have been new actions to this contract opportunity. To view the most recent action, please click here.

Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information

  • Contract Opportunity Type: Solicitation (Updated)
  • Updated Published Date: Mar 08, 2021 03:49 pm EST
  • Original Published Date: Mar 04, 2020 06:02 pm EST
  • Updated Date Offers Due: Oct 31, 2021
  • Original Date Offers Due: Mar 04, 2020
  • Inactive Policy: Manual
  • Updated Inactive Date: Oct 31, 2021
  • Original Inactive Date: Oct 31, 2020
  • Initiative:
    • None

Classification

  • Original Set Aside:
  • Product Service Code: AN13 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
  • NAICS Code:
    • 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
  • Place of Performance:
    Washington , DC 20515
    USA

Description

We appreciate your interest in partnering with BARDA.  Due to the COVID-19 response, any white papers or full proposal submissions, other than those that are in support of COVID-19, will be put into a queue.  Once the response to COVID-19 has subsided, we will resume normal review of submissions for other research areas of interest.  BARDA will not be able to meet the timelines highlighted in the Broad Agency Announcement.  Thank you for understanding this unprecedented response and delays that will occur.

The latest BARDA Broad Agency Announcement (BAA) is amendment 23 posted on March 8, 2021.

Note: COVID-19 response related Areas of Interest includes:

  • AOI 7.7.1 Diagnostic Assay for Human Coronaviruses
  • AOI 7.7.2 Diagnostic Assay for Detection of SARS-CoV-2 Virus
  • AOI 7.7.3 Diagnostic Assay for Detection of COVID-19 Neutralizing Antibodies
  • AOI 7.7.5 Screening Tests at Point of Care (2-minute Time to Result) 
  • AOI 9.2 COVID-19 Therapeutics
  • AOI 17 Advanced Manufacturing Technologies

All contracting related inquiries should be sent to BARDA-BAA@hhs.gov. BARDA revised, suspended, added sub-Area of Interest 7.7 Emerging Diseases Diagnostics and suspended AOI 12.2 Vaccine Production Platform. BARDA will continuously review and expedite COVID-19 response related white papers and full proposals. Offerors should also complete the Submission Data Integration Table.

The final white paper submission deadline extended to October 31, 2021. The final full proposal submission deadline extended to October 31, 2021 or as specified in the invitation letter.

Contact Information

Contracting Office Address

  • 200 Independence Avenue, SW
  • Washington , DC 20201
  • USA

Primary Point of Contact

Secondary Point of Contact

History